nodes	percent_of_prediction	percent_of_DWPC	metapath
Bendroflumethiazide—Hypotensive—Betamethasone—ankylosing spondylitis	0.0619	0.0619	CcSEcCtD
Bendroflumethiazide—Hypotensive—Dexamethasone—ankylosing spondylitis	0.0619	0.0619	CcSEcCtD
Bendroflumethiazide—Allergic cutaneous angiitis—Methotrexate—ankylosing spondylitis	0.0517	0.0517	CcSEcCtD
Bendroflumethiazide—Gastric irritation—Prednisone—ankylosing spondylitis	0.0507	0.0507	CcSEcCtD
Bendroflumethiazide—Epigastric discomfort—Prednisone—ankylosing spondylitis	0.0374	0.0374	CcSEcCtD
Bendroflumethiazide—Leukocytoclastic vasculitis—Methotrexate—ankylosing spondylitis	0.0335	0.0335	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Prednisolone—ankylosing spondylitis	0.0226	0.0226	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Triamcinolone—ankylosing spondylitis	0.0208	0.0208	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Methylprednisolone—ankylosing spondylitis	0.0207	0.0207	CcSEcCtD
Bendroflumethiazide—Vascular purpura—Triamcinolone—ankylosing spondylitis	0.0202	0.0202	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Betamethasone—ankylosing spondylitis	0.0188	0.0188	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Dexamethasone—ankylosing spondylitis	0.0188	0.0188	CcSEcCtD
Bendroflumethiazide—Purpura—Triamcinolone—ankylosing spondylitis	0.0187	0.0187	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Prednisolone—ankylosing spondylitis	0.0166	0.0166	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Prednisone—ankylosing spondylitis	0.0164	0.0164	CcSEcCtD
Bendroflumethiazide—Vascular purpura—Prednisone—ankylosing spondylitis	0.016	0.016	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Triamcinolone—ankylosing spondylitis	0.0153	0.0153	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Methylprednisolone—ankylosing spondylitis	0.0153	0.0153	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Dexamethasone—ankylosing spondylitis	0.0149	0.0149	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Betamethasone—ankylosing spondylitis	0.0149	0.0149	CcSEcCtD
Bendroflumethiazide—Urine output increased—Methotrexate—ankylosing spondylitis	0.0149	0.0149	CcSEcCtD
Bendroflumethiazide—Purpura—Prednisone—ankylosing spondylitis	0.0148	0.0148	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Methotrexate—ankylosing spondylitis	0.0137	0.0137	CcSEcCtD
Bendroflumethiazide—Polyuria—Methotrexate—ankylosing spondylitis	0.0136	0.0136	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Prednisone—ankylosing spondylitis	0.013	0.013	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Prednisone—ankylosing spondylitis	0.0121	0.0121	CcSEcCtD
Bendroflumethiazide—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.0114	0.0114	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Methotrexate—ankylosing spondylitis	0.0101	0.0101	CcSEcCtD
Bendroflumethiazide—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00949	0.00949	CcSEcCtD
Bendroflumethiazide—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00828	0.00828	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00789	0.00789	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00789	0.00789	CcSEcCtD
Bendroflumethiazide—Anorexia—Dexamethasone—ankylosing spondylitis	0.00768	0.00768	CcSEcCtD
Bendroflumethiazide—Anorexia—Betamethasone—ankylosing spondylitis	0.00768	0.00768	CcSEcCtD
Bendroflumethiazide—Hypotension—Betamethasone—ankylosing spondylitis	0.00753	0.00753	CcSEcCtD
Bendroflumethiazide—Hypotension—Dexamethasone—ankylosing spondylitis	0.00753	0.00753	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.007	0.007	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.007	0.007	CcSEcCtD
Bendroflumethiazide—Anorexia—Prednisone—ankylosing spondylitis	0.00669	0.00669	CcSEcCtD
Bendroflumethiazide—Dizziness—Prednisolone—ankylosing spondylitis	0.00638	0.00638	CcSEcCtD
Bendroflumethiazide—Asthenia—Triamcinolone—ankylosing spondylitis	0.00637	0.00637	CcSEcCtD
Bendroflumethiazide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00635	0.00635	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Prednisone—ankylosing spondylitis	0.0061	0.0061	CcSEcCtD
Bendroflumethiazide—Rash—Prednisolone—ankylosing spondylitis	0.00609	0.00609	CcSEcCtD
Bendroflumethiazide—Dermatitis—Prednisolone—ankylosing spondylitis	0.00608	0.00608	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00606	0.00606	CcSEcCtD
Bendroflumethiazide—Constipation—Prednisone—ankylosing spondylitis	0.006	0.006	CcSEcCtD
Bendroflumethiazide—Dizziness—Triamcinolone—ankylosing spondylitis	0.00587	0.00587	CcSEcCtD
Bendroflumethiazide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00586	0.00586	CcSEcCtD
Bendroflumethiazide—Asthenia—Betamethasone—ankylosing spondylitis	0.00578	0.00578	CcSEcCtD
Bendroflumethiazide—Asthenia—Dexamethasone—ankylosing spondylitis	0.00578	0.00578	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00574	0.00574	CcSEcCtD
Bendroflumethiazide—Nausea—Prednisolone—ankylosing spondylitis	0.00573	0.00573	CcSEcCtD
Bendroflumethiazide—Vomiting—Triamcinolone—ankylosing spondylitis	0.00564	0.00564	CcSEcCtD
Bendroflumethiazide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00563	0.00563	CcSEcCtD
Bendroflumethiazide—Rash—Triamcinolone—ankylosing spondylitis	0.0056	0.0056	CcSEcCtD
Bendroflumethiazide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00559	0.00559	CcSEcCtD
Bendroflumethiazide—Anorexia—Methotrexate—ankylosing spondylitis	0.00559	0.00559	CcSEcCtD
Bendroflumethiazide—Rash—Methylprednisolone—ankylosing spondylitis	0.00558	0.00558	CcSEcCtD
Bendroflumethiazide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00558	0.00558	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00551	0.00551	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00551	0.00551	CcSEcCtD
Bendroflumethiazide—Hypotension—Methotrexate—ankylosing spondylitis	0.00548	0.00548	CcSEcCtD
Bendroflumethiazide—Dizziness—Betamethasone—ankylosing spondylitis	0.00533	0.00533	CcSEcCtD
Bendroflumethiazide—Dizziness—Dexamethasone—ankylosing spondylitis	0.00533	0.00533	CcSEcCtD
Bendroflumethiazide—Nausea—Triamcinolone—ankylosing spondylitis	0.00527	0.00527	CcSEcCtD
Bendroflumethiazide—Nausea—Methylprednisolone—ankylosing spondylitis	0.00526	0.00526	CcSEcCtD
Bendroflumethiazide—Vomiting—Dexamethasone—ankylosing spondylitis	0.00512	0.00512	CcSEcCtD
Bendroflumethiazide—Vomiting—Betamethasone—ankylosing spondylitis	0.00512	0.00512	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.0051	0.0051	CcSEcCtD
Bendroflumethiazide—Rash—Betamethasone—ankylosing spondylitis	0.00508	0.00508	CcSEcCtD
Bendroflumethiazide—Rash—Dexamethasone—ankylosing spondylitis	0.00508	0.00508	CcSEcCtD
Bendroflumethiazide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00507	0.00507	CcSEcCtD
Bendroflumethiazide—Dermatitis—Betamethasone—ankylosing spondylitis	0.00507	0.00507	CcSEcCtD
Bendroflumethiazide—Asthenia—Prednisone—ankylosing spondylitis	0.00503	0.00503	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Prednisone—ankylosing spondylitis	0.0048	0.0048	CcSEcCtD
Bendroflumethiazide—Nausea—Betamethasone—ankylosing spondylitis	0.00478	0.00478	CcSEcCtD
Bendroflumethiazide—Nausea—Dexamethasone—ankylosing spondylitis	0.00478	0.00478	CcSEcCtD
Bendroflumethiazide—Dizziness—Prednisone—ankylosing spondylitis	0.00464	0.00464	CcSEcCtD
Bendroflumethiazide—Vomiting—Prednisone—ankylosing spondylitis	0.00446	0.00446	CcSEcCtD
Bendroflumethiazide—Rash—Prednisone—ankylosing spondylitis	0.00442	0.00442	CcSEcCtD
Bendroflumethiazide—Dermatitis—Prednisone—ankylosing spondylitis	0.00442	0.00442	CcSEcCtD
Bendroflumethiazide—Asthenia—Methotrexate—ankylosing spondylitis	0.00421	0.00421	CcSEcCtD
Bendroflumethiazide—Nausea—Prednisone—ankylosing spondylitis	0.00417	0.00417	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00401	0.00401	CcSEcCtD
Bendroflumethiazide—Dizziness—Methotrexate—ankylosing spondylitis	0.00388	0.00388	CcSEcCtD
Bendroflumethiazide—Vomiting—Methotrexate—ankylosing spondylitis	0.00373	0.00373	CcSEcCtD
Bendroflumethiazide—Rash—Methotrexate—ankylosing spondylitis	0.0037	0.0037	CcSEcCtD
Bendroflumethiazide—Dermatitis—Methotrexate—ankylosing spondylitis	0.00369	0.00369	CcSEcCtD
Bendroflumethiazide—Nausea—Methotrexate—ankylosing spondylitis	0.00348	0.00348	CcSEcCtD
